Literature DB >> 7919969

Immunohistochemical analysis of perforin and granzyme A in inflammatory myopathies.

S Orimo1, R Koga, K Goto, K Nakamura, M Arai, M Tamaki, H Sugita, I Nonaka, K Arahata.   

Abstract

Perforin (PF) and granzyme A (GA) are candidates suspected of being cytolytic proteins of the granules of cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells. We analysed PF and GA in muscles from patients with inflammatory myopathies. Five cases of polymyositis (PM), two cases of inclusion body myositis (IBM), and five cases of dermatomyositis (DM) were studied immunohistochemically using anti-PF and GA antibodies raised against each synthetic peptide of human PF and mouse GA, together with a panel of monoclonal antibodies reactive for lymphocyte subsets. In PM and IBM, PF positive cells were colocalized with GA positive cells and occasionally invaded into the non-necrotic muscle fibres. The percentage of PF positive cells among the endomysial CD8 positive cell population was 9.9% (PM) and 12.5% (IBM), and the majority of the endomysial CD8 positive cells were alpha/beta T cells. In contrast, in DM, both PF and GA positive cells were very few in all cases. Only few inflammatory cells were CD16+ or CD57+ NK cells among these diseases. Our results suggest that PF and GA are secreted mainly from alpha/beta T cells, and may play a key role in muscle fibre damage in at least some PM and IBM, but not in DM.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7919969     DOI: 10.1016/0960-8966(94)90022-1

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  13 in total

Review 1.  Inclusion body myositis.

Authors:  M J Garlepp; F L Mastaglia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

2.  Expression of granulysin in polymyositis and inclusion-body myositis.

Authors:  K Ikezoe; S Ohshima; M Osoegawa; M Tanaka; K Ogawa; K Nagata; J-i Kira
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10       Impact factor: 10.154

Review 3.  Risk factors and disease mechanisms in myositis.

Authors:  Frederick W Miller; Janine A Lamb; Jens Schmidt; Kanneboyina Nagaraju
Journal:  Nat Rev Rheumatol       Date:  2018-04-20       Impact factor: 20.543

4.  Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis.

Authors:  N Goebels; D Michaelis; M Engelhardt; S Huber; A Bender; D Pongratz; M A Johnson; H Wekerle; J Tschopp; D Jenne; R Hohlfeld
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

Review 5.  Targeted immunotherapy trials for idiopathic inflammatory myopathies.

Authors:  Joerg-Patrick Stübgen
Journal:  J Neurol       Date:  2012-06-30       Impact factor: 4.849

6.  Clonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR, and CDR3-spectratype analysis.

Authors:  Monika Hofbauer; Solveigh Wiesener; Holger Babbe; Axel Roers; Hartmut Wekerle; Klaus Dornmair; Reinhard Hohlfeld; Norbert Goebels
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-21       Impact factor: 11.205

Review 7.  Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies.

Authors:  Cecilia Grundtman; Vivianne Malmström; Ingrid E Lundberg
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 8.  Immune and myodegenerative pathomechanisms in inclusion body myositis.

Authors:  Christian W Keller; Jens Schmidt; Jan D Lünemann
Journal:  Ann Clin Transl Neurol       Date:  2017-05-16       Impact factor: 4.511

9.  T-cell transcriptomics from peripheral blood highlights differences between polymyositis and dermatomyositis patients.

Authors:  Miranda Houtman; Louise Ekholm; Espen Hesselberg; Karine Chemin; Vivianne Malmström; Ann M Reed; Ingrid E Lundberg; Leonid Padyukov
Journal:  Arthritis Res Ther       Date:  2018-08-29       Impact factor: 5.156

10.  Apoptosis in idiopathic inflammatory myopathies with partial invasion; a role for CD8+ cytotoxic T cells?

Authors:  Olof Danielsson; Bo Häggqvist; Liv Gröntoft; Karin Öllinger; Jan Ernerudh
Journal:  PLoS One       Date:  2020-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.